Potomac structures Oury Medical’s fundraising round alongside Isalt and family offices for the acquisition of Céfimeca
Based in Haute-Marne, the historic cradle of orthopedics, Oury Medical is a French group
specialized in orthopedic surgical instrumentation.
Driven by its new shareholder since 2022, TAG Partners, Oury Medical has experienced strong growth, increasing its revenue from €4M to €25M in 2025.
This growth is supported by an acquisition strategy aimed at building a comprehensive one-stop-shop offering in orthopedic surgical instrumentation.
In 2026, the acquisition of Céfimeca adds €13M of additional revenue and allows the group to enter the implant segment.
With five production sites in France and over 200 employees, Oury Medical has now reached a
critical size for its clients, with the ambition of becoming a European leader.



